Ignite Creation Date:
2024-05-06 @ 6:53 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05815628
Status:
RECRUITING
Last Update Posted:
2024-05-13
First Post:
2023-03-09
Brief Title:
Next-Generation-Sequencing Approach to Neutropenic Sepsis
Sponsor:
Boris Böll
Organization:
University Hospital of Cologne
Study Overview
Official Title:
Next-Generation-Sequencing Approach to Neutropenic Sepsis
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NEXUS
Brief Summary:
The aim of this prospective observational non-interventional multi-centre study of the diagnostic use of DISQVER in neutropenic patients with FN is to provide further evidence of the efficacy of an NGS-based approach for detecting bloodstream infection in neutropenic patients
Detailed Description:
The aim of this prospective observational non-interventional multi-centre study of the diagnostic use of DISQVER Platform for digital pathogen diagnostics from Noscendo GmbH in neutropenic patients with FN Febrile neutropenia is to provide further evidence of the efficacy of an NGS Next-generation seqzencing-based approach for detecting bloodstream infection in neutropenic patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None